leadf
logo-loader
viewRio Tinto PLC
(
LSE:RIO
)

Rio Tinto downgraded to ‘hold’ by Deutsche Bank after iron ore bears capitulation, other miners get share price boost

Analysts expect iron ore prices to normalise through the second half of 2021 and 2022, although near-term fundamentals remain very tight

Rio Tinto PLC - Rio Tinto downgraded to ‘hold’ by Deutsche Bank after iron ore bears capitulation, other miners get share price boost

Rio Tinto PLC (LON:RIO) was downgraded to ‘hold’ from ‘buy’ by Deutsche Bank after iron ore bears saw a “complete capitulation” in the second half of 2020.

Analysts boosted the target price to 6,000p from 5,100p, adding they expect iron ore prices to normalise through the second half of 2021 and 2022, although near-term fundamentals remain very tight.

READ: Miners ride 2020 rollercoaster and come off in strong position

Meanwhile, the recovery in coking coal prices would be ex-China led through the first half.

The German bank also upgraded the target prices of Anglo American PLC (LON:AAL) to 3,000p from 2,600p, of Antofagasta PLC (LON:ANTO) to 1,100p from 940p, of BHP (LON:BHP) to 2,050p from 1,700p and of Glencore PLC (LON:GLEN) to 320p from 250p.

The higher estimates reflect the broad-based risk rally in the fourth quarter and generally positive fundamentals for the sector, although the copper market is expected to remain in a sustained deficit over the medium term and reach a peak price of US$8,200 per tonne in the second quarter of 2021.

“Sustained demand strength in China, a post vaccine activity bounce in the West together with rising expectations for major (green) fiscal stimulus should remain positive underpins to the cycle in 2021,” analysts commented.

Rio Tinto and Antofagasta shed 1% to 6,067p and 1,533.5p respectively, Anglo American and BHP remained flat while Glencore added 1% to 279.8p on Thursday late morning.

Quick facts: Rio Tinto PLC

Follow
LSE:RIO

Price: 4707 GBX

Market Cap: £76.21 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

CBD Science Group looks to raise £2M in a Series A round to advance its...

CBD Science Group PLC CEO Dr Michael Raymont joined Proactive New York to discuss the London, England-based group's Series A funding round, on the Crowd for Angels platform. Raymont says the privately-held company, which is developing plant-based cannabinoid pharmaceutical therapeutics to...

2 hours, 33 minutes ago

2 min read